Critical Reviews in Oncology Hematology

Papers
(The H4-Index of Critical Reviews in Oncology Hematology is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Tyrosine kinase inhibitors in cancers: Treatment optimization – Part II341
Microbiome dynamics in breast cancer: Mechanisms, therapeutic impacts and research gaps219
Bidirectional role of neutrophils in lung cancer: Mechanisms and therapeutic implications172
A systematic review and meta-analysis of blood-based biomarkers in anal squamous cell cancer treated with chemoradiotherapy128
Skin barrier dysfunction in cutaneous T-cell lymphoma: From pathogenic mechanism of barrier damage to treatment109
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era106
Comparative efficacy of first-line therapies for PD-L1-negative advanced NSCLC: A network meta-analysis with reconstructed survival curves100
Double agents in immunotherapy: Unmasking the role of antibody drug conjugates in immune checkpoint targeting81
Editorial Board77
Beyond the blood-brain barrier: Intranasal vaccines in cancer immunotherapy70
Real-world analysis of primary central nervous system diffuse large B-cell lymphoma67
Efficacy of PD-1/PD-L1 immunotherapy on brain metastatic non-small-cell lung cancer and treatment-related adverse events: A systematic review66
Novel insight into the Warburg effect: Sweet temptation65
Advancing tumor vaccines: Overcoming TME challenges, delivery strategies, and biomaterial-based vaccine for enhanced immunotherapy62
The role of cGAS-STING in remodeling the tumor immune microenvironment induced by radiotherapy60
Current status of locally advanced rectal cancer therapy and future prospects59
The cytokines in tumor microenvironment: from cancer initiation-elongation-progression to metastatic outgrowth58
Direct and indirect effects on child neurocognitive development when maternal cancer is diagnosed during pregnancy: What do we know so far?54
A non-invasive miRNA-based approach in early diagnosis and therapeutics of oral cancer54
Systemic immune-inflammation index as a predictor of survival in non-small cell lung cancer patients undergoing immune checkpoint inhibition: A systematic review and meta-analysis53
Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions53
Mapping the research landscape of HPV-positive oropharyngeal cancer: a bibliometric analysis52
Letter to the Editor regarding the article “A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs app52
Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies49
Spatial multiomics of the breast tumour microenvironment: State of the field, advancements and clinical implementation promises48
Beyond monospecificity: The modular revolution of bispecific immunotherapeutics48
Dysregulation of systemic immunity in colorectal cancer and its clinical applications as biomarkers and therapeutics47
Instruments and scales for the evaluation of acute radiation dermatitis: A systematic review45
Navigating management of localized prostate cancer in the geriatric population44
Stereotactic body radiation therapy versus conventional external beam radiation therapy for painful bone metastases: A systematic review and meta-analysis of randomized trials42
Novel bioengineered drugs with immunotherapies for malignant pleural effusion: Remodulate tumor immune microenvironment and activate immune system41
Total neoadjuvant treatment and organ preservation strategies in the management of localized rectal cancer: A narrative review and evidence-based algorithm41
The hidden hand of endoplasmic reticulum stress in anticancer drug resistance40
Surface-Enhanced Raman Scattering (SERS) combined with machine learning enables accurate diagnosis of cervical cancer: From molecule to cell to tissue level40
Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models40
Targeted doublet therapy with encorafenib and cetuximab for BRAF V600E-mutant metastatic colorectal cancer: A systematic review and meta-analysis40
Harnessing tumor metabolism during cancer treatment: A narrative review of emerging dietary approaches39
Stereotactic body radiotherapy as an alternative to brachytherapy in cervical cancer (SCORE): A systematic review and meta-analysis39
Development of treatment strategies for advanced HER2-positive gastric cancer: Insights from clinical trials39
0.15343022346497